Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Acute stroke in patients on new direct oral anticoagulants: how to manage, how to treat?

Epple C, Steiner T.

Expert Opin Pharmacother. 2014 Oct;15(14):1991-2001. doi: 10.1517/14656566.2014.938638. Epub 2014 Jul 11. Review.

PMID:
25014495
2.

Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Seiffge DJ, Hooff RJ, Nolte CH, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz JF, De Marchis GM, Bonati LH, Peters N, Charidimou A, Werring DJ, Palm F, Reinhard M, Niesen WD, Nagao T, Pezzini A, Caso V, Nederkoorn PJ, Kägi G, von Hessling A, Padjen V, Cordonnier C, Erdur H, Lyrer PA, Brouns R, Steiner T, Tatlisumak T, Engelter ST; NOACISP Study Group*..

Circulation. 2015 Sep 29;132(13):1261-9. doi: 10.1161/CIRCULATIONAHA.115.015484. Epub 2015 Jul 31.

3.

Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.

Folyovich A, Varga V, Béres-Molnár KA, Vadasdi K, Bereczki D.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):580-2. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.029. Epub 2013 May 28.

PMID:
23721623
4.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P; Working Group on Perioperative Haemostasis..

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.

5.

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

Cheng JW, Barillari G.

J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3. Review.

PMID:
24383983
6.

New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.

Yasaka M.

Front Neurol Neurosci. 2015;37:93-106. doi: 10.1159/000437116. Epub 2015 Nov 12. Review.

PMID:
26588018
7.

Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.

Hankey GJ.

Thromb Haemost. 2014 May 5;111(5):808-16. doi: 10.1160/TH13-09-0741. Epub 2013 Nov 28. Review.

PMID:
24285341
8.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
9.

The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?

Hammwöhner M, Goette A.

J Cardiovasc Pharmacol. 2015 Dec;66(6):530-9. doi: 10.1097/FJC.0000000000000297. Review.

PMID:
26222990
10.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Steiner T, Böhm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M, Laufs U, Nickenig G, Riess H, Röther J, Schellinger PD, Spannagl M, Veltkamp R.

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14. Review.

PMID:
23669868
11.

Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

Ploen R, Sun L, Zhou W, Heitmeier S, Zorn M, Jenetzky E, Veltkamp R.

J Cereb Blood Flow Metab. 2014 Mar;34(3):495-501. doi: 10.1038/jcbfm.2013.226. Epub 2013 Dec 18.

12.

Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol.

Kepplinger J, Prakapenia A, Barlinn K, Siegert G, Gehrisch S, Zerna C, Beyer-Westendorf J, Puetz V, Reichmann H, Siepmann T, Bodechtel U.

J Thromb Thrombolysis. 2016 Feb;41(2):293-300. doi: 10.1007/s11239-015-1229-z.

PMID:
26001908
13.

Safe intravenous thrombolysis in acute stroke despite treatment with rivaroxaban.

Bornkamm K, Harloff A.

J Clin Neurosci. 2014 Nov;21(11):2012-3. doi: 10.1016/j.jocn.2014.03.017. Epub 2014 Jun 15.

PMID:
24938385
14.

Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.

Albert NM.

Heart Lung. 2014 Jan-Feb;43(1):48-59. doi: 10.1016/j.hrtlng.2013.10.014. Epub 2013 Nov 11. Review.

PMID:
24373340
15.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Martí-Fàbregas J, Mateo J.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3. Review.

PMID:
19342840
16.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
17.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
18.

Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.

Diener HC, Foerch C, Riess H, Röther J, Schroth G, Weber R.

Lancet Neurol. 2013 Jul;12(7):677-88. doi: 10.1016/S1474-4422(13)70101-7. Epub 2013 May 31. Review.

PMID:
23726849
19.

Upstream versus downstream thrombin inhibition.

Gulpen AJ, Ten Cate-Hoek AJ, Ten Cate H.

Expert Rev Cardiovasc Ther. 2016 Nov;14(11):1273-1282. doi: 10.1080/14779072.2016.1224179. Epub 2016 Aug 30. Review.

PMID:
27575701
20.

Supplemental Content

Support Center